P778 Real-world drug treatment costs for ulcerative colitis and Crohn’s disease patients treated with vedolizumab vs. anti-TNFα: Results from a German retrospective chart review study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.